ID
22012
Description
Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin; ODM derived from: https://clinicaltrials.gov/show/NCT00691912
Link
https://clinicaltrials.gov/show/NCT00691912
Keywords
Versions (1)
- 5/14/17 5/14/17 -
Uploaded on
May 14, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Metastatic Breast Cancer NCT00691912
Eligibility Metastatic Breast Cancer NCT00691912
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
high dose therapy with stem cell support
Data type
boolean
Alias
- UMLS CUI [1]
- C1512429
Description
cumulative anthracycline dose, epirubicin, doxorubicin, mitoxantrone
Data type
boolean
Alias
- UMLS CUI [1,1]
- C2986497
- UMLS CUI [1,2]
- C0282564
- UMLS CUI [1,3]
- C0014582
- UMLS CUI [1,4]
- C0013089
- UMLS CUI [1,5]
- C0026259
Description
concomitant hormone, chemo-, radiotherapy
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1707479
- UMLS CUI [1,2]
- C0279025
- UMLS CUI [1,3]
- C0392920
- UMLS CUI [1,4]
- C1522449
Description
her2 neu
Data type
boolean
Alias
- UMLS CUI [1]
- C1512413
Description
pregnancy, breast feeding
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0032961
- UMLS CUI [1,2]
- C0006147
Similar models
Eligibility Metastatic Breast Cancer NCT00691912
- StudyEvent: Eligibility
C0079399 (UMLS CUI [1,2])
C0001779 (UMLS CUI [1,3])
C0282564 (UMLS CUI [1,2])
C0014582 (UMLS CUI [1,3])
C0013089 (UMLS CUI [1,4])
C0026259 (UMLS CUI [1,5])
C0279025 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C1522449 (UMLS CUI [1,4])
C0006147 (UMLS CUI [1,2])